Filing Details

Accession Number:
0001144204-15-001664
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-09 19:00:24
Reporting Period:
2015-01-07
Filing Date:
2015-01-09
Accepted Time:
2015-01-09 19:00:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Pharmathene Inc PIP Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535179 L Linda Chang C/O Pharmathene, Inc.,
One Park Place, Ste 450
Annapolis MD 21401
Svp, Cfo & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.0001 Par Value Per Share Acquisiton 2015-01-07 29,600 $1.13 59,600 No 4 M Direct
Common Stock, $0.0001 Par Value Per Share Disposition 2015-01-07 29,600 $2.10 30,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to Purchase Disposition 2015-01-07 29,600 $0.00 29,600 $1.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
45,400 2022-12-03 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2014.
  2. These shares were sold in multiple transactions all at the same price of $2.10 per share.
  3. These options were part of a grant of 75,000 options on 12/03/2012, which vest 25% on each of the first, second, third and fourth anniversaries of the grant date.